NCT05739591View on ClinicalTrials.gov

Long-term Safety and Efficacy of GBG Study Participants

RecruitingOBSERVATIONAL

Enrollment

400

Participants

Timeline

Start Date

October 12, 2022

Primary Completion Date

May 19, 2030

Study Completion Date

May 19, 2030

Conditions

Breast Cancer

Trial Locations (3)

4020

RECRUITING

Ordensklinikum Linz GmbH - BHS, Linz

5020

RECRUITING

LKH Salzburg - PMU, Salzburg

6020

RECRUITING

MUI - Univ. Klinik f. Frauenheilkunde Innsbruck, Innsbruck

All Listed Sponsors

lead

GBG Forschungs GmbH

OTHER